In the non-oncology drug space, pharmacy benefit managers have become a lot more aggressive; however, it remains to be seen whether or not the same will eventually happen in the oncology space, said John L. Fox, MD, MHA.
He added that while the panelists had discussed accountability among providers for cost and outcomes, they hadn’t yet touched upon the issue of accountability among manufacturers of drugs, devices, or diagnostics.
“I think it’s an emerging area of interest,” he said. “We have a contract with a manufacturer that says if their drug doesn't achieve the progression free survival that they found in their clinical trial, that there will be a reimbursement to the plan.”
What Priority Health is doing in that instance differs from holding companies accountable for a patient-by-patient basis to see if the drugs are performing, pointed out Scott Gottlieb, MD. Instead, Priority is holding manufacturers accountable on a global scale to demonstrate post-market what they found in the clinical trial.
Ted Okon added that there have been talks between manufacturers and CMS to consider these agreements, and there seems to be some agreement on both sides that this may be worth pursuing. However, there are structural impediments in the Medicare system that may mean CMS cannot just issue new regulations, but new legislation may need to be drafted.
“I think the challenge in all of this though is: do we have the data to adjudicate a pay-for-outcomes contract,” said Dr Fox.
Can Medicare Sustain Widespread Access to GLP-1 Therapies?
April 25th 2025Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Science at AACR Aims to Overcome Cancer Care Barriers
April 24th 2025A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for Cancer Research annual meeting runs April 25-30, with the key presentations coming Sunday through Tuesday.
Read More
Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas
April 24th 2025Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las Vegas, Nevada.
Read More